GERO

Gero are a company utilizing whole-exome sequencing data for in-human AI drug discovery. The company aims to identify rare gene mutations that significantly influence health and then screens for drugs that can mimic or inhibit that target gene to treat diseases. They suggest their platform can aggregate the effects of multiple gene mutations and provide a druggable solution to target them simultaneously. Gero believes that aging is a natural part of the human development program, and they are developing ways to understand, measure, and, ultimately, control it.